AMRI has received a 10-year federal contract from the National Institutes of Health (NIH) for drug development and manufacturing services to support NIH’s Drug Manufacturing and Formulation Program (DMFP), a component of the Blueprint Neurotherapeutics Network (BPN). AMRI has supported the NIH BPN since 2011, providing chemistry services and discovery technologies and since 2005, AMRI has collaborated with NINDS in the area of medicinal chemistry on treatments for spinal muscular atrophy, ...